当前位置：
X-MOL 学术
›
Ther. Adv. Med. Oncol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
New frontiers in the medical management of gastrointestinal stromal tumours
Therapeutic Advances in Medical Oncology ( IF 4.3 ) Pub Date : 2019-05-17 , DOI: 10.1177/1758835919841946 Alessandro Mazzocca 1 , Andrea Napolitano 1 , Marianna Silletta 1 , Mariella Spalato Ceruso 1 , Daniele Santini 1 , Giuseppe Tonini 1 , Bruno Vincenzi 2
Therapeutic Advances in Medical Oncology ( IF 4.3 ) Pub Date : 2019-05-17 , DOI: 10.1177/1758835919841946 Alessandro Mazzocca 1 , Andrea Napolitano 1 , Marianna Silletta 1 , Mariella Spalato Ceruso 1 , Daniele Santini 1 , Giuseppe Tonini 1 , Bruno Vincenzi 2
Affiliation
Gastrointestinal stromal tumours (GISTs) are the most common mesenchymal neoplasms, with a global annual incidence of 10–15 cases per million.1–3 GISTs arise from the interstitial cells of Cajal4 primarily in the gastrointestinal (GI) tract, with the majority found in the stomach (60%),3 although extra-GI sites of origin are possible.5,6
中文翻译：
胃肠道间质瘤医疗管理的新领域
胃肠道间质瘤（GIST）是最常见的间质肿瘤，全球每年的发病率为每百万例10-15例。1-3 GISTs起源于Cajal 4的间质细胞，主要在胃肠道（GI），在胃中占多数（60％），尽管3可能起源于GI。5,6
更新日期：2019-05-17
中文翻译：
胃肠道间质瘤医疗管理的新领域
胃肠道间质瘤（GIST）是最常见的间质肿瘤，全球每年的发病率为每百万例10-15例。1-3 GISTs起源于Cajal 4的间质细胞，主要在胃肠道（GI），在胃中占多数（60％），尽管3可能起源于GI。5,6
京公网安备 11010802027423号